{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:44:35Z","timestamp":1772743475619,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.jsbmb.2006.01.006","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T15:19:35Z","timestamp":1145373575000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Association of SULT2A1 allelic variants with plasma adrenal androgens and prostate cancer in African American men"],"prefix":"10.1016","volume":"99","author":[{"given":"Teresa W.","family":"Wilborn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas P.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreelatha","family":"Meleth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles N.","family":"Falany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsbmb.2006.01.006_bib1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1096\/fasebj.11.4.9068609","article-title":"Enzymology of human cytosolic sulfotransferases","volume":"11","author":"Falany","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.jsbmb.2006.01.006_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev.pharmtox.40.1.159","article-title":"Pharmacogenetics of sulfotransferase","volume":"40","author":"Yamazoe","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.jsbmb.2006.01.006_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bj2600641","article-title":"Purification and characterization of human liver dehydroepiandrosterone sulphotransferase","volume":"260","author":"Falany","year":"1989","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.jsbmb.2006.01.006_bib4","first-page":"234","article-title":"Immunohistochemical localization of dehydroepiandrosterone sulfotransferase in human fetal tissues","volume":"78","author":"Parker","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.jsbmb.2006.01.006_bib5","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0090-9556(25)08470-3","article-title":"Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation","volume":"24","author":"Her","year":"1996","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.jsbmb.2006.01.006_bib6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1210\/jcem-54-6-1216","article-title":"Umbilical cord plasma levels of dehydroepiandrosterone sulfate during human gestation","volume":"54","author":"Parker","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2006.01.006_bib7","series-title":"The Endocrine Function of the Human Adrenal Cortex","first-page":"561","article-title":"Developmental patterns of the plasma level of testosterone, androstenedione, 17-hydroxyprogesterone, dehydroepiandrosterone and its sulfate in normal infants and prepubertal children","author":"Forest","year":"1978"},{"issue":"8","key":"10.1016\/j.jsbmb.2006.01.006_bib8","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1210\/jcem.82.8.4161","article-title":"Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology","volume":"82","author":"Labrie","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2006.01.006_bib9","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2006.01.006_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/oxfordjournals.jncimonographs.a024244","article-title":"The role of steroid hormones in prostate carcinogenesis","volume":"27","author":"Bosland","year":"2000","journal-title":"J. Natl. Cancer Inst. Monogr."},{"issue":"4 Pt. 1","key":"10.1016\/j.jsbmb.2006.01.006_bib11","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.ju.0000139539.94828.29","article-title":"Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia","volume":"172","author":"Andriole","year":"2004","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.jsbmb.2006.01.006_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/sj.tpj.6500089","article-title":"Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies","volume":"2","author":"Thomae","year":"2002","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.jsbmb.2006.01.006_bib13","author":"Society","year":"2001","journal-title":"Cancer Facts Fig."},{"issue":"2","key":"10.1016\/j.jsbmb.2006.01.006_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/1055-9965.EPI-03-0047","article-title":"Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians","volume":"13","author":"Nowell","year":"2004","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"3","key":"10.1016\/j.jsbmb.2006.01.006_bib15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2004.04.181","article-title":"Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group","volume":"22","author":"Freedland","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2006.01.006_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.1995.tb17372.x","article-title":"Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization","volume":"774","author":"Falany","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jsbmb.2006.01.006_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/frne.2001.0216","article-title":"DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology","volume":"22","author":"Labrie","year":"2001","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.jsbmb.2006.01.006_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1995.tb17378.x","article-title":"Metabolism of dehydroepiandrosterone","volume":"774","author":"Longcope","year":"1995","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4\u20135","key":"10.1016\/j.jsbmb.2006.01.006_bib19","first-page":"261","article-title":"Expression and characterization of the human 3 beta-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b)","volume":"77","author":"Falany","year":"2001","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.jsbmb.2006.01.006_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1124\/dmd.30.5.582","article-title":"Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST)","volume":"30","author":"Meloche","year":"2002","journal-title":"Drug Metab. Dispos."},{"issue":"11","key":"10.1016\/j.jsbmb.2006.01.006_bib21","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/carcin\/19.11.2007","article-title":"Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts","volume":"19","author":"Shibutani","year":"1998","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.jsbmb.2006.01.006_bib22","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1124\/dmd.104.000919","article-title":"Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase STa","volume":"32","author":"Duffel","year":"2004","journal-title":"Drug. Metab. Dispos."},{"issue":"4\u20135","key":"10.1016\/j.jsbmb.2006.01.006_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jsbmb.2004.01.005","article-title":"Sulfation of tibolone and tibolone metabolites by expressed human cytosolic sulfotransferases","volume":"88","author":"Falany","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076006000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076006000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:52:06Z","timestamp":1760734326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076006000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":23,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0960076006000628"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2006.01.006","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of SULT2A1 allelic variants with plasma adrenal androgens and prostate cancer in African American men","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2006.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}